The effectiveness of Echinacea extract or composite glucosamine, chondroitin and methyl sulfonyl methane supplements on acute and chronic rheumatoid arthritis rat model

Toxicology and Industrial Health

Volumn 29, Issue 2, 2013, Pages 187-201

  Arafa, Nadia Ms ^a   Hamuda, Hayam M ^b   Melek, Samuel T ^b   Darwish, Sahar K ^b  

^a JAZAN UNIVERSITY   (Saudi Arabia)

^b NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

Author keywords

Bacterial outer membrane protein; chondroitin sulphate; Echinacea; glucosamine; methyl sulfonyl methane; rheumatic markers

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CHONDROITIN SULFATE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ECHINACEA EXTRACT; GENUPHIL; GLUCOSAMINE SULFATE; METHYL SULFONYL METHANE; OUTER MEMBRANE PROTEIN; RHEUMATOID FACTOR; SULFUR DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; CITROBACTER; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; FECES MICROFLORA; FEMALE; HUMAN; INFLAMMATION; NONHUMAN; PAW EDEMA; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; RAT; RHEUMATOID ARTHRITIS; SALMONELLA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SYNOVIOCYTE; SYNOVIUM;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CHONDROITIN SULFATES; COMPLEX MIXTURES; DIETARY SUPPLEMENTS; DIMETHYL SULFOXIDE; DISEASE MODELS, ANIMAL; ECHINACEA; FEMALE; GLUCOSAMINE; LYSOSOMES; PLANT EXTRACTS; RATS; STIFLE; SULFONES;

EID: 84874404311     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233711428643     Document Type: Article

References (91)

1. Agarwal V, Malaviya AN (2005) Cytokine network and its manipulation in rheumatoid arthritis. Journal of the Indian Rheumatology Association 13: 86–91.
2. Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A et al. (2004) Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Annals of the Rheumatic Diseases 63(10): 1218–1221.
3. Ames GFL, Spudich EN, Nikaido H (1974) Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations. The Journal of Bacteriology 117(2): 406–416.
4. Ameye LG, Chee WS (2006) Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Research and Therapy 8(4): R127.
5. Aoki S (1999) Rheumatoid arthritis and enteric bacteria. Modern Rheumatology 9(4): 325–352.
6. Arafa NMS (2010) Efficacy of Echinacea on the action of cyproterone acetate in male rats. Pakistan Journal of Biological Sciences 13(20): 966–976.
7. Arafa NMS, Salem SM, Farid OAH (2010) Influence of echinacea extract pre- or postnatal supplementation on immune and oxidative status of growing rabbits. Italian Journal of Animal Science e63(3): 338–343.
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism 31(3): 315–324.
9. Bainbridge J, Madden L, Essex D, Binks M, Malhotra R, Paleolog EM (2007) Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition. Arthritis Research and Therapy 9(6): R127.
10. Banchroft JD, Stevens A, Turner DR (1996) Theory and Practice of Histological Techniques. 4th ed. New York: Churchil Livingstone.
11. Baranauskas A, Bernatonienė J, Radžiūnas R, Bernatonis D (2005) Imuninę sistemą gerinančio ekstrakto technologijos ypatybės. [Technology of extract improving the immune system.] Medicina (Kaunas) 41(8): 693–697.
12. Barcz E, Sommer E, Nartowska J, Balan B, Chorostowska-Wynimko J, Skopińska-Rózewska E et al. (2007) Influence of Echinacea purpurea intake during pregnancy on fetal growth and tissue angiogenic activity. Folia histochemica et cytobiologica 45(1): 35–39.
13. Bos MP, Robert V, Tommassen J (2007) Biogenesis of the gram-negative bacterial outer membrane. Annual Review of Microbiology 61: 191–214.
14. Burtis CA, Ashwood ER (1999) Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia: WB Saunders Co., 49.
15. Chan PS, Caron JP, Rosa GJ, Orth MW (2005) Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis and Cartilage 13(5): 287–294.
16. Chen HA, Lin KC, Chen CH, Liao HT, Wang HP, Chang HN et al. (2006) The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 65(1): 35–39.
17. Choi DW, Kim MJ, Kim HS, Chang SH, Jung GS, Shin KY, et al. (2003) A size-exclusion HPLC method for the determination of sodium chondroitin sulfate in pharmaceutical preparations. Journal of Pharmaceutical and Biomedical Analysis 31(6): 1229–1236.
18. Chow G (2006) Dietary Echinacea purpurea during murine pregnancy: effect on maternal hemopoiesis and fetal growth. Biology of the Neonate 89(2): 133–136.
19. Dalby-Brown L (2005) Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human lowdensity lipoproteins. Journal of Agriculture and Food Chemistry 53(24): 9413–9423.
20. Dovanti A, Bignamini AA, Rovati AL (1980) Therapeutic activity of oral glucosamine sulphate in osteoarthrosis: a placebo-controlled double-blind investigation. Clinical Therapeutics 3(4): 260–272.
21. Eyre DR, Wu JJ (1995) Collagen structure and cartilage matrix integrity. The Journal of Rheumatology 43: 82–85.
22. Fathi NA, Ezz-Eldin AM, Mosad E, Bakry RM, Hamed HB, Ahmed S et al. (2008) Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis. International Archives of Medicine 1(1): 20.
23. Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85: 307–310.
24. Fenton JI, Chlebek-Brown KA, Peters TL, Caron JP, Orth MW (2000) Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthritis and Cartilage 8(4): 258–265.
25. FitzGerald O, Bresnihan B (1995) Synovial membrane cellularity and vascularity. Annals of Rheumatic Diseases 54(6): 511–515.
26. Goldenberg DL, Cohen AS (1978) Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine (Baltimore) 57(3): 239–252.
27. Gouze JN, Bianchi A, Bécuwe P, Dauça M, Netter P, Magdalou J et al. (2002) Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κB pathway. FEBS Letters 510(3): 166–170.
28. Hasegawa T (2004) Suppressive effect of methylsulfonylmethane (MSM) on type II collagen-induced arthritis in DBA/1J mice. Japanese Journal of Pharmacology and Therapeutics 32(7): 421–427.
29. Hathcock JH, Shao A (2007) Risk assessment for glucosamine and chondroitin sulfate. Regulatory Toxicology and Pharmacology 47(1): 78–83.
30. Horváth K, Noker PE, Somfai-Relle S, Glávits R, Financsek I, Schauss AG (2002) Toxicity of methylsulfonylmethane in rats. Food and Chemical Toxicology 40(10): 1459–1462.
31. Hosler P (2006) Biological therapies directed against cells in autoimmune disease. Seminars in Immunopathology 27(4): 443–456.
32. Hou CC, Chen CH, Yang NS, Chen YP, Lo CP, Wang SY et al. (2010) Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants. The Journal of Nutritional Biochemistry 21(11): 1045–1059.
33. Hu C (2000) Studies on the antioxidant activity of Echinacea root tincture. Journal of Agriculture and Food Chemistry 48(5): 1466–1468.
34. Huber LC, Distlor O, Tarner I, Gay RE, Gay S, Pap T (2006) Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 45(6): 669–673.
35. Jacob SW, Lawrence RM, Zucker M (1999) The Miracle of MSM: The Natural Solution for Pain. New York: G. P. Putnam's Sons, 57–58.
36. Jaroenviriyapap T, Vittayanont M (2009) Type and content of chondroitin sulphate and collagen in poultry tracheas. Asian Journal of Food and Agro-Industry 2(4): 974–980.
37. Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF (2006) Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis and Cartilage 14(3): 286–294.
38. Kim YH, Kim DH, Lim H, Baek DY, Shin HK, Kim JK (2009) The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biological and Pharmaceutical Bulletin 32(4): 651–656.
39. Largo R, Alvarez-Soria MA, Diez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J et al. (2003) Glucosamine inhibits IL-1B-induced NFκB activation in human osteoarthritic chondrocytes. Osteoarthritis and Cartilage 11(4): 290–298.
40. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atherosclerosis. American Journal of Physiology Heart and Circulatory Physiology 288(5): 2031–2041.
41. Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic disease. Annals of the Rheumatic Diseases 62(9): 870–874.
42. Liang Z, Leslie J, Adebowale A, Ashraf M, Eddington ND (1999) Determination of the nutraceutical, glucosamine hydrochloride, in raw materials, dosage forms and plasma using pre-column derivatization with ultraviolet HPLC. Journal of Pharmaceutical and Biomedical Analysis 20(5): 807–814.
43. Lippiello L (2003) Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthritis and Cartilage 11(5): 355–342.
44. Lippiello L, Woodward J, Karpman R, Hammad TA (2000) In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clinical Orthopaedics and Related Research (381): 229–240.
45. Liu Y, Murphy PA (2007) Alkamide stability in Echinacea purpurea extracts with and without phenolic acids in dry films and in solution. Journal of Agricultural and Food Chemistry 55(1): 120–126.
46. Lugtenberg B, Meijers J, Peters R, van der Hoek P, van Alphen L (1975) Electrophoretic resolution of the ‘major outer membrane protein’ of Escherichia coli K-12 into four bands. FEBS Letters 58(1): 254–258.
47. Magnuson BA, Appleton J, Ryan B, Matulka RA (2007) Oral developmental toxicity study of methylsulfonylmethane in rats. Food and Chemical Toxicology 45(6): 977–984.
48. Majithia V, Geraci SA (2007) Rheumatoid arthritis: diagnosis and management. The American Journal of Medicine 120(11): 936–939.
49. Masteikova R, Muselik J, Bernatonienė J, Bernatonienė R (2007) Antioxidative activity of Ginkgo, Echinacea, and Ginseng tinctures. Medicina (Kaunas) 43(4): 306–330.
50. Matsuno H, Nakamura H, Katayama K, Hayashi S, Kano S, Yudoh K et al. (2009) Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis. Bioscience, Biotechnology, and Biochemistry 73(2): 288–292.
51. McCarthy G, O’Donovan J, Jones B, McAllister H, Seed M, Mooney C (2007) Randomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis. Veterinary Journal 174(1): 54–61.
52. Melchart D, Clemm C, Weber B, Draczynski T, Worku F, Linde K et al. (2002) Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy—a pilot study. Phytotherapy Research 16(2): 138–142.
53. Mor A, Abramson SB, Pillinger MH (2005) The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clinical Immunology 115(2): 118–128.
54. Murav’ev IuV, Venikova MS, Pleskovskaia GN, Riazantseva TA, Sigidin IaA (1991) Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis. Patologicheskaia fiziologiia ieksperimental’naia terapiia (2): 37–39.
55. Newkirk MM, Zbar A, Baron M, Manges AR (2010) Distinct bacterial colonization patterns of Escherichia coli subtypes associate with rheumatoid factor status in early inflammatory arthritis. Rheumatology (Oxford) 49(7): 1311–1316.
56. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S et al. (2007) Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Annals of Internal Medicine 146(11): 797–808.
57. O'Dell J (2004) Therapeutic strategies for rheumatoid arthritis. The New England Journal of Medicine 350(25): 2591–2602.
58. Paroli E, Antonilli L, Biffoni M (1991) A pharmacological approach to glycosaminoglycans. Drugs under Experimental and Clinical Research 17(1): 9–19.
59. Patrick CYW, Kenneth HLN, Susanna KPL, Kam-tong Y, Ami MYF, Kit-wah L et al. (2003) Usefulness of the Microseq 500 16 S Ribosomal DNA-based bacterial identification system for identification of clinical significant bacterial isolates with ambiguous biochemical profiles. Journal of Clinical Microbiology 41(5): 1996–2001.
60. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. The Journal of Clinical Investigation 111(12): 1805–1812.
61. Pettinari A (2006) Effect of polyphenolic compounds on the proteolytic activities of constitutive and immuno-proteasomes. Antioxidants and Redox Signalling 8(1-2): 121–126.
62. Piperno M, Reboul P, Hellio Le Graverand M, Peshard M, Annefeld M, Richard M et al. (2000) Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro. Osteoarthritis and Cartilage 8(3): 207–212.
63. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis and Rheumatism 48(10): 2741–2749.
64. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. The FASEB Journal 22(3): 659–661.
65. Rezende MU, Gurgel HM, Vilaça Junior PR, Kuroba RK, Lopes AS, Phillipi RZ et al. (2006) Diacerhein versus glucosamine in a rat model of osteoarthritis. Clinics (Sao Paulo) 61(5): 461–466.
66. Roman M, Benjamin RL (2008) Determination of methylsulfonylmethane (MSM) content in raw materials and dietary supplements by GC-FID: collaborative study. The Journal of AOAC International 91(6).
67. Rosenbaum CC, O'Mathúna DP, Chavez M, Shields K (2010) Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Alternative Therapies in Health and Medicine 16(2): 32–40.
68. Schiraldi C, Cimini D, De Rosa M (2010) Production of chondroitin sulfate and chondroitin. Applied Microbiology and Biotechnology 87(4): 1209–1220.
69. Schrijver IA, Melief MJ, Tak PP, Hazenberg MP, Laman JD (2000) Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. Arthritis and Rheumatism 43(10): 2160–2168.
70. Setnikar I, Rovati LC (2001) Absorption, distribution, metabolism and excretion of glucosamine sulfate. Arzneimitteforschun 51(9): 699–725.
71. Severijnen AJ, van Kleef R, Hazenberg MP, van de Merwe JP (1989) Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats. The Journal of Rheumatology 16(8): 1061–1068.
72. Sharma SM, Anderson M, Schoop SR, Hudson JB (2010) Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce): dual actions against respiratory bacteria. Phytomedicine 17(8–9): 563–568.
73. Singh YP, Singh AK, Aggarwal A, Misra R (2011) Evidence of cellular immune response to outer membrane protein of Salmonella typhimurium in patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. The Journal of Rheumatology 38(1): 161–166.
74. Song YS, Jin C, Park EH (2000) Identification of phytosterols in rat feces using GC/MS. Archives of Pharmacal Research 23(6): 599–604.
75. Stimpson SA, Lerch RA, Cleland DR (1987) Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments. Infection and Imunnity 55(1): 16–23.
76. Stone M, Fortin PR, Pacheco-Tena C, Inman RD (2003) Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. Journal of Rheumatology 30(10): 2112–2122.
77. Svärd A, Kastbom A, Söderlin MK, Reckner-Olsson A, Skogh T (2011) A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis. The Journal of Rheumatology 38(7): 1265–1272.
78. Toivanen P (2003) Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis. Annals of Rheumatic Disease 62(9): 807–811.
79. Tokuda H (2009) Biogenesis of outer membranes in gram-negative bacteria. Bioscience Biotechnology, and Biochemistry 73(3): 465–473.
80. Towheed TE, Maxwell L, Anastassiades TP et al. (2005) Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews 2 CD002946. PMID 15846645.
81. Usha PR, Naidu MU (2004) Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Investigation 24(6): 353–363.
82. van der Heijden IM, Wilbrink B, Tchetverikov I, Schrijver IA, Schouls LM, Hazenberg MP et al. (2000) Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis and Rheumatism 43(3): 593–598.
83. van Venrooij WJ, Zendman AJ, Pruijn GJ (2006) Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmunity Reviews 6(1): 37–41.
84. Wen ZH, Tang CC, Chang YC, Huang SY, Hsieh SP, Lee CH et al. (2010) Glucosamine sulfate reduces experimental osteoarthritis and nociception in rats: association with changes of mitogen-activated protein kinase in chondrocytes. Osteoarthritis and Cartilage 18(9): 1192–1202.
85. Westwood OM, Nelson PN, Hay FC (2006) Rheumatoid factors: what's new? Rheumatology (Oxford) 45(4): 379–385.
86. Zendman AJW, Van Venrooij WJ, Prujin GJM (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 45(1): 20–25.
87. Zhang N, Cui HD, Xue HX (2008) Effect of local viral transfer of interleukin 10 gene on a rabbit arthritis model induced by interleukin 1beta. Chinese Medical Journal 121(5): 435–438.
88. Zhang X, Rimpilainen M, Hoffmann B, Simelyte E, Aho H, Toivanen P (2001a) Experimental chronic arthritis and granulomatous inflammation induced by bifidobacterium cell walls. Scandinavian Journal of Immunology 54(1-2): 171–179.
89. Zhang X, Rimpilainen M, Simelyte E, Toivanen P (2001b) Characterisation of Eubacterium cell wall: peptidoglycan structure determines arthritogenicity. Annals of the Rheumatic Disease 60(3): 269–274.
90. Zhang X, Rimpiläinen M, Simelyte E, Toivanen P (2000) What determines arthritogenicity of bacterial cell wall? A study on Eubacterium cell wall-induced arthritis. Rheumatology (Oxford) 39(3): 274–282.
91. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM et al. (2000) Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. The American Journal of Cardiology 85(2): 140–146.